IntelGenx Technologies Corporation (IGXT)

OTCMKTS: IGXT · Delayed Price · USD
0.310
-0.006 (-1.74%)
May 18, 2022 11:42 AM - Market open
Market Cap48.03M
Revenue (ttm)731,000
Net Income (ttm)-9.74M
Shares Out154.95M
EPS (ttm)-0.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume14,103
Open0.338
Previous Close0.316
Day's Range0.293 - 0.345
52-Week Range0.230 - 0.650
Beta2.38
AnalystsBuy
Price Target1.02 (+229.0%)
Earnings DateMay 12, 2022

About IGXT

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients und...

IndustryPharmaceuticals
Founded2003
CEOHorst Zerbe
Employees4
Stock ExchangeOTCMKTS
Ticker SymbolIGXT
Full Company Profile

Analyst Forecast

According to 5 analysts, the average rating for IGXT stock is "Buy." The 12-month stock price forecast is 1.02, which is an increase of 229.03% from the latest price.

Price Target
$1.02
(229.03% upside)
Analyst Consensus: Buy
Stock Forecasts

News

IntelGenx to Report First Quarter 2022 Financial Results on May 12, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, May 05, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its firs...

1 week ago - GlobeNewsWire

IntelGenx to Participate in the 2022 Bloom Burton & Co. Healthcare Investor Conference

SAINT LAURENT, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that management will presen...

3 weeks ago - GlobeNewsWire

IntelGenx Reports Fourth Quarter and Full-Year 2021 Financial Results

SAINT LAURENT, Quebec, March 24, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the three- and twelve-mon...

1 month ago - GlobeNewsWire

IntelGenx to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022 – Conference Call to Follow

SAINT LAURENT, Quebec, March 17, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its fo...

2 months ago - GlobeNewsWire

First Patient Dosed in IntelGenx's Resumed ‘BUENA' Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mi...

SAINT LAURENT, Quebec, Jan. 20, 2022 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”), a leader in pharmaceutical films, today announced that patient dosing has ...

3 months ago - GlobeNewsWire

IntelGenx Initiates Arbitration Proceeding Against Tilray® Related to an Alleged Breach of Worldwide Cannabis-Infused...

SAINT LAURENT, Quebec, Dec. 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has initiated an arbitration proceeding against Til...

5 months ago - GlobeNewsWire

IntelGenx Reports Third Quarter 2021 Financial Results

SAINT LAURENT, Quebec, Nov. 11, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter ended S...

6 months ago - GlobeNewsWire

IntelGenx to Report Third Quarter 2021 Financial Results on November 11, 2021 – Conference Call to Follow

SAINT LAURENT, Quebec, Nov. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its thi...

6 months ago - GlobeNewsWire

IntelGenx Receives Final Approval to Graduate to Toronto Stock Exchange

SAINT LAURENT, Quebec, Oct. 05, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (“IntelGenx” or ”the “Company”) announces that it has received final approval to graduate ...

7 months ago - GlobeNewsWire

IntelGenx and Aquestive Therapeutics Partner with Leading Men's Health Company to Market Tadalafil Oral Films in the ...

SAINT LAURENT, Quebec, Sept. 29, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that its co-development and commercialization partner for Tadalafil oral f...

7 months ago - GlobeNewsWire

IntelGenx Receives U.S.$6 Million in Additional Loans from atai Life Sciences and Conditional Approval to Graduate to...

SAINT LAURENT, Quebec, Sept. 15, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company”) announces that its wholly-owned subsidiary, IntelGenx Corp. (“IntelGenx”)...

8 months ago - GlobeNewsWire

IntelGenx Announces Market Launch of RIZAPORT® in Spain

SAINT LAURENT, Quebec, Sept. 07, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that Exeltis Healthcare S.L. (“Exeltis”), its commerciali...

8 months ago - GlobeNewsWire

IntelGenx Ships CBD Filmstrips to Heritage Cannabis in Support of Canadian Market Launch

SAINT LAURENT, Quebec, Aug. 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has completed an initial shipment of CBD Filmstrip...

8 months ago - GlobeNewsWire

IntelGenx Announces Closing of Notes Offering

SAINT LAURENT, Quebec, Aug. 05, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces the closing of an offering by way of private plac...

9 months ago - GlobeNewsWire

IntelGenx Reports Second Quarter 2021 Financial Results

SAINT LAURENT, Quebec, Aug. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter ended...

9 months ago - GlobeNewsWire

IntelGenx Announces Subscription for Notes

SAINT LAURENT, Quebec, July 27, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) (the “Company” or “IntelGenx”) announces that it has received subscriptions from investors...

9 months ago - GlobeNewsWire

IntelGenx's VetaFilm™ Platform to be Evaluated by One of the World's Fastest Growing Animal Healthcare Companies

SAINT LAURENT, Quebec, June 08, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it has entered into a Materials Tr...

11 months ago - GlobeNewsWire

IntelGenx Announces Noteholder Approval of Proposed Amendments to Convertible Notes

SAINT LAURENT, Québec, May 19, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Corporation”) today announced that the holders (“Noteholders”) of its 6...

11 months ago - GlobeNewsWire

IntelGenx Announces Initial Closing of atai Investment

SAINT LAURENT, Quebec, May 14, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today reported that the previously announce...

1 year ago - GlobeNewsWire

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of Second Feasibility Agreement

SAINT LAURENT, Quebec, May 12, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it has entered into a second feasib...

1 year ago - GlobeNewsWire

IntelGenx Announces Shareholder Approval of atai Investment

SAINT LAURENT, Quebec, May 11, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that a significant majority...

1 year ago - GlobeNewsWire

IntelGenx Announces Intention to Amend Convertible Unsecured Promissory Notes

SAINT LAURENT, Quebec, April 09, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it is proposing to a...

1 year ago - GlobeNewsWire

IntelGenx Ships First CBD Filmstrip Order to Heritage Cannabis

SAINT LAURENT, Quebec, March 31, 2021 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) ("Company" or "IntelGenx") today announced that, further to its press releases of January 7 and March 25...

1 year ago - GlobeNewsWire

IntelGenx Reports Fourth Quarter and Full-Year 2020 Financial Results

SAINT-LAURENT, Quebec, March 25, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter and ...

1 year ago - GlobeNewsWire

IntelGenx to Report Fourth Quarter and Full-Year 2020 Financial Results on March 25, 2021 – Conference Call to Follow

SAINT LAURENT, Quebec, March 18, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQB:IGXT) (“IntelGenx”) today announced that it will release its fourth quarter and full-year 2020 f...

1 year ago - GlobeNewsWire